Functionalized adhesive for medical devices

1. A method for adhering a medical device to biological tissue comprising:

providing a bifunctional adhesive composition having a plurality of reactive members of a first specific binding pair and a plurality of reactive members of a second specific binding pair;

providing tissue with a plurality of complementary reactive members of the first specific binding pair;

contacting the bifunctional adhesive composition with the biological tissue, wherein upon contact of the reactive members of the first specific binding pair associated with the bifunctional adhesive with the complimentary reactive members of the first specific binding pair associated with the tissue, covalent bonds are formed between the reactive members and the complementary reactive members of the first specific binding pair, thus adhering the bifunctional adhesive to the tissue;

providing a medical device having a plurality of complementary reactive members of the second specific binding pair;

contacting the medical device with the bifunctional adhesive, wherein upon contact of the reactive members of the second specific binding pair associated with the bifunctional adhesive with the complimentary reactive members of the second specific binding pair associated with the medical device, covalent bonds are formed between the reactive members and the complementary reactive members of the second specific binding pair, thus adhering the medical device to the biological tissue via the bifunctional adhesive composition.

2. The method for adhering a medical device to biological tissue according to claim 1 wherein the members of the first specific binding pair bind to one another via a reaction selected from the group consisting of Huisgen cycloaddition reaction, a Diels-Alder reaction and a thiol-ene reaction and the members of the second specific binding pair bind to one another via a reaction selected from the group consisting of Huisgen cycloaddition reaction, a Diels-Alder reaction and a thiol-ene reaction.

3. The method for adhering a medical device to biological tissue according to claim 2 wherein the members of the first specific binding pair are alkynes and azides.

4. The method for adhering a medical device to biological tissue according to claim 3 wherein the reactive member of the first specific binding pair is an alkyne and the complementary reactive member of the first specific binding pair is an azide.

5. The method for adhering a medical device to biological tissue according to claim 3 wherein the reactive members of the first specific binding pair is an azide and the complementary reactive member of the first specific binding pair is an alkyne.

6. The method for adhering a medical device to biological tissue according to claim 3 wherein the reaction is catalyzed by metal to activate an alkyne and an azide for [3+2] cycloaddition.

7. The method for adhering a medical device to biological tissue according to claim 3 wherein the reaction involves a cyclooctyne reagent and an azide for [3+2] cycloaddition.

8. The method for adhering a medical device to biological tissue according to claim 2 wherein the members of the first specific binding pair are thiols and alkenes.

9. The method for adhering a medical device to biological tissue according to claim 2 wherein the members of the first specific binding pair are dienes and alkenes.

10. The method for adhering a medical device to biological tissue according to claim 2 wherein the tissue is provided with complementary reactive members of the first specific binding pair by applying a mixture or an aerosol containing the complementary reactive members to the tissue, the complementary reactive members being conjugated to a linker adapted to link the complementary reactive members to the tissue.

11. The method for adhering a medical device to biological tissue according to claim 10 wherein the complementary reactive members are attached to the tissue via an RGD linker.

12. The method for adhering a medical device to biological tissue according to claim 10 wherein the complementary reactive members are attached to the tissue via a ligand-receptor linkage.

13. The method for adhering a medical device to biological tissue according to claim 12 wherein the complementary reactive members are conjugated to a linker selected from the group consisting of antibody, Fab, F(ab′) 2 , Fv, single chain antibody (SCA) and single complementary-determining region (CDR).

14. The method for adhering a medical device to biological tissue according to claim 10 wherein the linker is degraded by hydrolysis or enzymatic action.

15. The method for adhering a medical device to biological tissue according to claim 10 wherein the ligand binds to a receptor selected from the group consisting of peptides, oligosaccharides, oligonucleotides and lipids.

16. The method for adhering a medical device to biological tissue according to claim 1 wherein the bifunctional adhesive composition is a hydrogel made of a polymer selected from the group consisting of polysaccharides, mucopolysaccharides, polyaminoacids, proteins, collagen-hydroxyethyl methacrylate (HEMA), polyphosphazines, polyphosphoesters, poly(ethylene glycol), poly(ethylene oxide), poly(vinyl alcohol), polyvinylpyrrolidone, polyethyloxazoline, poly(ethylene oxide-co-propylene oxide) block copolymers, poly(glycolic acid)-poly(ethylene glycol)-poly(glycolic acid) (PGA-PEG-PGA) block copolymers, PGA-PEG diblock copolymers, PEG-oligoglycolylacrylates, polyacrylonitriles (PAN), carboxy alkyl celluloses, poly(α-hydroxy) acids, polylactones, polycaprolactones, polyanhydrides, polyorthoesters, polydioxanone, polystyrene, and combinations thereof.

17. The method for adhering a medical device to biological tissue according to claim 16 wherein the mucopolysacharrides are selected from the group consisting of hyaluronic acid, dextran, heparin sulfate, chondroitin sulfate, heparin, agar, starch, and alginate; the proteins are selected from the group consisting of fibronectin, gelatin, collagen, fibrin, pectins, albumin, ovalbumin, and polyamino acids; the carboxy alkyl celluloses are selected from the group consisting of carboxymethyl cellulose and partially oxidized cellulose; poly(α-hydroxy) acids selected from the group consisting of poly(glycolic acid), poly(D,L-lactic acid), poly(L-lactic acid), and terpolymers of DL-lactide and glycolide; and polylactones selected from the group consisting of poly(ε-caprolactone), poly(δ-valerolactone) and poly(γ-butyrolactone), ε-caprolactone copolymerized with polyesters.

18. The method for adhering a medical device to biological tissue according to claim 1 wherein the bifunctional adhesive composition includes a polymer selected from the group consisting of polycarbonates, polyolefins, polymethacrylates, polystyrenes, polyamides, polyurethanes, poly(ethylene terephthalate), poly(lactic acid), poly(glycolic acid), polyhydroxbutyrate, polydioxanones, poly(phosphazine), polyesters, polyacrylamides, cellulose esters, fluoropolymers, vinyl polymers, silk, collagen, chitin, chitosan, chondroitin sulfate, glycosaminoglycans, poly(hydroxyethyl methacrylate), polyvinylpyrrolidone, poly(acrylic acid), polyacetate, polycaprolactone, polypropylene, poly(amino acids), copoly(ether-esters), poly(alkylene oxalates), poly iminocarbonates, polyoxaesters, polyorthoesters, polyphosphazenes, polypeptides and combinations thereof.

19. The method for adhering a medical device to biological tissue according to claim 1 wherein the medical device is selected from the group consisting of scaffold, adhesion barrier, patch matrix, plug, bandage, mesh and prosthetic device.

20. The method for adhering a medical device to biological tissue according to claim 1 wherein the bifunctional adhesive composition is a liquid which is applied to the tissue.

21. The method for adhering a medical device to biological tissue according to claim 1 wherein the bifunctional adhesive composition is a preformed layer which is applied to the tissue.

22. The method for adhering a medical device to biological tissue according to claim 1 wherein the bifunctional adhesive composition is applied to the device before contacting with the tissue.

23. The method for adhering a medical device to biological tissue according to claim 1 wherein the bifunctional adhesive composition is applied to the tissue before contacting with the device.

24. The method for adhering a medical device to biological tissue according to claim 2 wherein the members of the second specific binding pair are alkynes and azides.

25. The method for adhering a medical device to biological tissue according to claim 24 wherein the reactive member of the second specific binding pair is an alkyne and the complementary reactive member of the second specific binding pair is an azide.

26. The method for adhering a medical device to biological tissue according to claim 24 wherein the reactive members of the second specific binding pair is an azide and the complementary reactive member of the second specific binding pair is an alkyne.

27. The method for adhering a medical device to biological tissue according to claim 24 wherein the reaction is catalyzed by metal to activate an alkyne and an azide for [3+2] cycloaddition.

28. The method for adhering a medical device to biological tissue according to claim 24 wherein the reaction involves a cyclooctyne reagent and an azide for [3+2] cycloaddition.

29. The method for adhering a medical device to biological tissue according to claim 2 wherein the members of the second specific binding pair are thiols and alkenes.

30. The method for adhering a medical device to biological tissue according to claim 2 wherein the members of the second specific binding pair are dienes and alkenes.